Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expeditors International of Wshngtn Inc (EXPD) vs Medtronic PLC (MDT) Price & Performance

Expeditors International of Wshngtn IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Expeditors International of Wshngtn Inc vs Medtronic PLC — how do they compare? Expeditors International of Wshngtn Inc trades at $193.52 (market cap $25.18B), while Medtronic PLC trades at $88.16 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 4.5× Expeditors International of Wshngtn Inc's market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Expeditors International of Wshngtn Inc for 43 Days and Medtronic PLC for 63 Days on average.

EXPDMDT
Market Cap
$25.18B$112.24B
Volume
1,003,557105,663,236
Sector
IndustrialsHealth
52-Week High
$194.12$105.35
52-Week Low
$113.13$73.75
Typical Hold Time
43 Days63 Days
Enterprise Value
$24.72B$131.58B
Dividend Yield
0.84%3.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expeditors International of Wshngtn Inc

EXPD trades at $190.85, down 0.5% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 expected at $2.20 EPS. Revenue growth is steady, rising from $10.6B in 2024 to a projected $12.0B in 2026, while net income margins remain stable around 7.6%. Recent news highlights efficiency initiatives and airfreight demand as positive catalysts.

Outlook is mixed: strong profitability and earnings beats support upside, but a high P/E of 28.2 suggests premium valuation risks. Analyst consensus is cautious with 63.6% hold ratings, and the consensus price target of $179.43 implies potential downside. Key risks include freight market volatility and execution challenges amid economic uncertainty.

Medtronic PLC

Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.

MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXPD
100% Buy0% Sell
Avg holding period · 43 Days
MDT
53% Buy47% Sell
Avg holding period · 63 Days

Top news

Latest headlines on both assets

About Expeditors International of Wshngtn Inc

Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.

Read more on EXPD →

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →